Analysis of China's Third Party medical diagnosis Industry in 2018: Molecular diagnosis is the development trend of medical diagnosis

Time：

2021-09-15

Independent medical laboratories (ICLs) : Also known as third-party testing, are companies that provide medical testing services independently of medical institutions. Its core is economies of scale, which means reducing unit cost and obtaining cost, quality and technology advantages through economies of scale, so as to achieve win-win results and reduce medical expenses. Its appearance not only solves the problem of inspection outsourcing of small and medium-sized medical institutions, but also solves the problem that large hospitals have to carry out loss-making inspection projects due to social needs. Now it has become an indispensable part of the medical service system.

In 2001, Guangzhou Kingfield Laboratory first commercialized the independent medical laboratory model, thus unveiling the development process of the independent medical laboratory in China. Since then, independent medical laboratories have spread rapidly across the country. Data shows that there were only 2 independent medical laboratories in 2001, but the number increased to 468 in 2016. Which passed the ISO15189 "medical laboratory - quality and ability of the special requirements" criteria there are 235 (ISO15189 is the current domestic medical laboratory accreditation standards high grade, international high standard reference to the United States CAP). It is expected that there will be more than 600 independent medical laboratories in 2017.

Development characteristics of the third party medical diagnosis industry

From the perspective of the development of the third-party medical diagnosis industry, it mainly has the advantages of first mover and brand effect, with a certain service radius, asset-light operation, few talents and so on.